C07K 7/02
Linear peptides containing at least one abnormal peptide link
C07K7/02 (Linear peptides containing at least one abnormal peptide link) appears on 714 US grants and 757 published applications in this corpus.
Search patents in C07K- Granted patents
- 714
- Published applications
- 757
- Assignees
- 447
- Inventors
- 1,932
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 7 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 12 | 0 |
| 1993 | 8 | 0 |
| 1994 | 12 | 0 |
| 1995 | 13 | 0 |
| 1996 | 20 | 0 |
| 1997 | 24 | 0 |
| 1998 | 28 | 0 |
| 1999 | 28 | 0 |
| 2000 | 20 | 0 |
| 2001 | 20 | 5 |
| 2002 | 11 | 24 |
| 2003 | 23 | 26 |
| 2004 | 12 | 15 |
| 2005 | 15 | 23 |
| 2006 | 23 | 30 |
| 2007 | 10 | 25 |
| 2008 | 13 | 25 |
| 2009 | 15 | 24 |
| 2010 | 20 | 27 |
| 2011 | 13 | 21 |
| 2012 | 12 | 36 |
| 2013 | 29 | 38 |
| 2014 | 25 | 33 |
| 2015 | 20 | 32 |
| 2016 | 33 | 34 |
| 2017 | 14 | 27 |
| 2018 | 39 | 45 |
| 2019 | 29 | 46 |
| 2020 | 26 | 39 |
| 2021 | 24 | 37 |
| 2022 | 30 | 39 |
| 2023 | 20 | 29 |
| 2024 | 21 | 36 |
| 2025 | 17 | 23 |
| 2026 | 7 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases7 Jul 2026US 12,673,974 B2Protagonist Therapeutics, Inc.
- Exon skipping by peptide nucleic acid derivatives12 May 2026US 12,624,068 B2OliPass Corporation
- Cyclic compounds for treating cancer28 Apr 2026US 12,612,431 B2University of South Florida
- HLA tumor antigen peptides of class I and II for treating mammary/breast carcinomas31 Mar 2026US 12,589,142 B2Pmcr GmbH
- NRP-1 binding inhibitory peptides and uses thereof31 Mar 2026US 12,590,122 B2Assistance Publique-Hopitaux de Paris
- Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases24 Sep 2026US 2026/0285908 A1Protagonist Therapeutics, Inc.
- Lipooligoureas, pharmaceutical composition, and lipooligoureas for use as medicament27 Aug 2026US 2026/0248748 A1Uniwersytet Warszawski
- Tnfr1-inhibitory cyclic peptide having non-natural amino acid structure20 Aug 2026US 2026/0242420 A1Asahi Kasei Pharma Corporation
- Novel fungal derived compounds20 Aug 2026US 2026/0242430 A1Aalborg Universitet
- Novel and stable compstatin analogues13 Aug 2026US 2026/0234189 A1Boehringer Ingelheim International GmbH
Most cited
By later US patents
- Monomethylvaline compounds capable of conjugation to ligands486US 7,498,298 B2Seattle Genetics, Inc. · 2009
- Peptide nucleic acid combinatorial libraries and improved methods of synthesis408US 5,539,083 AIsis Pharmaceuticals, Inc. · 1996
- Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides270US 5,663,149 AArizona Board of Regents acting on behalf of Arizona State University · 1997
- Peptide derivatives201US 6,124,431 ATeikoku Hormone Mfg. Co., Ltd. · 2000
- Peptide derivatives186US 5,767,237 ATeikoku Hormone Mfg. Co., Ltd. · 1998